Cargando…
Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M
Thrombocytopenia and increased platelet clearance observed in von Willebrand disease-type 2B (VWD-2B) may be explained by platelet apoptosis triggered by the constitutive binding of VWF to its receptor, glycoprotein Ib (GPIb). Apoptosis was assessed in platelets from two patients with a severe VWD-2...
Autores principales: | Berrou, Eliane, Kauskot, Alexandre, Adam, Frédéric, Harel, Amélie, Legendre, Paulette, Lavenu Bombled, Cécile, Rothschild, Chantal, Prevost, Nicolas, Christophe, Olivier D., Lenting, Peter J., Denis, Cécile V., Rosa, Jean-Philippe, Bryckaert, Marijke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672890/ https://www.ncbi.nlm.nih.gov/pubmed/26645283 http://dx.doi.org/10.1371/journal.pone.0143896 |
Ejemplares similares
-
A thrombopoietin receptor agonist to rescue an unusual platelet
transfusion-induced reaction in a p.V1316M-associated von Willebrand disease
type 2B patient
por: Casari, Caterina, et al.
Publicado: (2022) -
Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014) -
In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor
por: Badirou, Idinath, et al.
Publicado: (2012) -
A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation
por: Adam, Frédéric, et al.
Publicado: (2016) -
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence
por: Dupont, Annabelle, et al.
Publicado: (2019)